AUPS317302A0 - Metastable pharmaceutical compositions - Google Patents
Metastable pharmaceutical compositionsInfo
- Publication number
- AUPS317302A0 AUPS317302A0 AUPS3173A AUPS317302A AUPS317302A0 AU PS317302 A0 AUPS317302 A0 AU PS317302A0 AU PS3173 A AUPS3173 A AU PS3173A AU PS317302 A AUPS317302 A AU PS317302A AU PS317302 A0 AUPS317302 A0 AU PS317302A0
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- metastable
- metastable pharmaceutical
- compositions
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS3173A AUPS317302A0 (en) | 2002-06-25 | 2002-06-25 | Metastable pharmaceutical compositions |
BR0312003-1A BR0312003A (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical compositions for transdermal delivery and their uses |
AU2003240299A AU2003240299B2 (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical compositions |
PCT/AU2003/000785 WO2004000361A1 (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical compositions |
NZ537436A NZ537436A (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical compositions |
JP2004514438A JP2005534670A (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical composition |
EA200500083A EA012648B1 (en) | 2002-06-25 | 2003-06-24 | Pharmaceutical composition for transdermal active agent delivery (variants) |
EP03729714A EP1531867A4 (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical compositions |
KR1020047020966A KR20050120726A (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical compositions |
CA002490057A CA2490057A1 (en) | 2002-06-25 | 2003-06-24 | Metastable pharmaceutical compositions |
US11/019,542 US20050181032A1 (en) | 2002-06-25 | 2004-12-23 | Metastable pharmaceutical compositions |
JP2010172167A JP2010248250A (en) | 2002-06-25 | 2010-07-30 | Metastable pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS3173A AUPS317302A0 (en) | 2002-06-25 | 2002-06-25 | Metastable pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPS317302A0 true AUPS317302A0 (en) | 2002-07-18 |
Family
ID=3836732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPS3173A Abandoned AUPS317302A0 (en) | 2002-06-25 | 2002-06-25 | Metastable pharmaceutical compositions |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1531867A4 (en) |
JP (2) | JP2005534670A (en) |
KR (1) | KR20050120726A (en) |
AU (1) | AUPS317302A0 (en) |
BR (1) | BR0312003A (en) |
CA (1) | CA2490057A1 (en) |
EA (1) | EA012648B1 (en) |
NZ (1) | NZ537436A (en) |
WO (1) | WO2004000361A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013024084A2 (en) | 2011-03-22 | 2016-12-06 | Population Council Inc | methods for remyelination of a patient, and for treating multiple sclerosis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0794378B2 (en) * | 1989-08-18 | 1995-10-11 | 久光製薬株式会社 | Aerosol |
JPH0383924A (en) * | 1989-08-28 | 1991-04-09 | Kanebo Ltd | Composition for percutaneous administration |
JP2974081B2 (en) * | 1990-07-26 | 1999-11-08 | 小池化学株式会社 | Aerosol composition for human body |
WO1992006675A1 (en) * | 1990-10-18 | 1992-04-30 | Minnesota Mining And Manufacturing Company | Aerosol formulation comprising beclomethasone 17,21 dipropionate |
CA2101496A1 (en) * | 1992-07-31 | 1994-02-01 | Masao Kobayashi | Base for transdermal administration |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
DE19616539A1 (en) * | 1996-04-25 | 1997-11-06 | Luitpold Pharma Gmbh | Alcoholic solutions containing acetylsalicylic acid for percutaneous use, their use for antithrombotic therapy and medicines |
US5968919A (en) * | 1997-10-16 | 1999-10-19 | Macrochem Corporation | Hormone replacement therapy drug formulations for topical application to the skin |
DE60006069T2 (en) * | 1999-02-05 | 2004-07-29 | Cipla Ltd. | TOPICAL SPRAYS CONTAINING A FILM-FORMING COMPOSITION |
US6368618B1 (en) * | 1999-07-01 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
AU2001286995B2 (en) * | 2000-08-30 | 2006-11-30 | Besins Healthcare Luxembourg Sarl | Method for treating erectile dysfunction and increasing libido in men |
JP2004507511A (en) * | 2000-08-30 | 2004-03-11 | ユニメッド・ファーマシューティカルズ・インコーポレーテッド | Methods for increasing testosterone and related steroid levels in women |
-
2002
- 2002-06-25 AU AUPS3173A patent/AUPS317302A0/en not_active Abandoned
-
2003
- 2003-06-24 BR BR0312003-1A patent/BR0312003A/en not_active IP Right Cessation
- 2003-06-24 JP JP2004514438A patent/JP2005534670A/en not_active Withdrawn
- 2003-06-24 WO PCT/AU2003/000785 patent/WO2004000361A1/en active Application Filing
- 2003-06-24 EA EA200500083A patent/EA012648B1/en not_active IP Right Cessation
- 2003-06-24 CA CA002490057A patent/CA2490057A1/en not_active Abandoned
- 2003-06-24 NZ NZ537436A patent/NZ537436A/en not_active IP Right Cessation
- 2003-06-24 EP EP03729714A patent/EP1531867A4/en not_active Withdrawn
- 2003-06-24 KR KR1020047020966A patent/KR20050120726A/en not_active Application Discontinuation
-
2010
- 2010-07-30 JP JP2010172167A patent/JP2010248250A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EA012648B1 (en) | 2009-12-30 |
EA200500083A1 (en) | 2005-08-25 |
JP2010248250A (en) | 2010-11-04 |
CA2490057A1 (en) | 2003-12-31 |
WO2004000361A1 (en) | 2003-12-31 |
KR20050120726A (en) | 2005-12-23 |
EP1531867A1 (en) | 2005-05-25 |
BR0312003A (en) | 2005-03-22 |
EP1531867A4 (en) | 2011-03-23 |
NZ537436A (en) | 2007-01-26 |
JP2005534670A (en) | 2005-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2389530B (en) | Pharmaceutical compositions | |
AU2003291103A1 (en) | Pharmaceutical composition | |
AU2003302603A1 (en) | Improved opioid pharmaceutical compositions | |
EP1425019A4 (en) | Pharmaceutical composition | |
GB2391473B (en) | Pharmaceutical compositions | |
AU2003276549A1 (en) | Pharmaceutical compositions containing a biguanide-glitazone combination | |
AU2003250372A1 (en) | Pharmaceutical composition | |
AU2002302147A1 (en) | Pharmaceutical composition | |
AU2003269904A1 (en) | Antigen-polymer compositions | |
GB0213481D0 (en) | Pharmaceutical compositions | |
AU2003284460A1 (en) | Medicinal composition | |
AU2003216503A1 (en) | Stable pharmaceutical compositions | |
AU2003280799A1 (en) | Medicinal composition | |
AU2003208841A1 (en) | Gasolinen compositions | |
AU2003280678A1 (en) | Medicinal composition | |
AUPS317302A0 (en) | Metastable pharmaceutical compositions | |
PL370907A1 (en) | Pharmaceutical compositions | |
AU2003216382A1 (en) | Idothyronine compositions | |
AUPR529701A0 (en) | Pharmaceutical composition | |
AUPS188302A0 (en) | Pharmaceutical composition | |
AU2003218497A1 (en) | FACTORVIIa COMPOSITIONS | |
AU2002335161A1 (en) | Medicinal composition | |
AUPS167102A0 (en) | Pharmaceutical composition | |
AUPS124202A0 (en) | Pharmaceutical composition | |
AU2002100921A4 (en) | Pharmaceutical composition |